Broadening Your Approach to Trial Diversity on a Global Scale

“Diversity” means different things to different individuals and cultures, with no one-size-fits-all definition capturing the concept’s many complexities.

This webinar explored diversity through a global lens by tapping into the perspectives of industry leaders who addressed how we can broaden access to a wide range of underrepresented groups, including those who possess attributes linked to troubling and challenging health disparities. Presenters looked at varying cultural perspectives of diversity in clinical research and discussed the role of clinical trial sites, study teams, and sponsors in expanding a more impactful and globally enabled definition of inclusive research so that you can walk away with insights on making meaningful diversity contributions for reducing health disparities and accelerating health equity worldwide.

Upon completion of this continuing education program, participants should be able to:

• Describe how definitions and perspectives on diversity differ across cultures.
• Discuss globalized definitions and considerations for diversity in clinical research.
• Apply global diversity considerations to clinical trial strategies.

Speakers:

• Liz Beatty, Co-Founder and Chief Strategy Officer, Inato
• Adewale Lawrence, MD, MSc, Founder/Independent Clinical Development Consultant, BioLuminux
• Lloryn Hubbard, Director, Patient Diversity Clinical Research, PPD, part of Thermo Fisher Scientific
• Sarah Bridges, BScKin, MAHSR, Research Coordinator, Maritime SPOR SUPPORT Unit, Horizon Health Network

Approved for 1.0 ACRP Contact Hours | Expires November 8, 2026